A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy
Xiaochun Hu, Ruihao Li, Wenjing Wu, Kang Fang, Zhounan Zhu, Yixuan Wang, Lulu Zhou, Mengyao Chen, Chunyan Dong, Shuo Shi
Topics & Concepts
OxaliplatinProdrugChemistryCancer researchPharmacologyChemotherapyTumor microenvironmentGlutathioneBiochemistryCancerMedicineInternal medicineColorectal cancerEnzymeTumor cellsNanoplatforms for cancer theranosticsFerroptosis and cancer prognosisCancer Immunotherapy and Biomarkers